Y. Lin, X. Chen, Z. Lin, and W. Yan, “Dexmedetomidine alleviates high glucose-induced podocyte damage by inhibiting EDA2R”, Trop. J. Pharm Res, vol. 21, no. 9, pp. 1885–1891, Oct. 2022.